Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma
CompletedOBSERVATIONAL
Enrollment
200
Participants
Timeline
Start Date
July 31, 1998
Study Completion Date
May 31, 2002
Conditions
Non-Hodgkin Lymphoma
Trial Locations (1)
20892
National Cancer Institute (NCI), Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00026910 - Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter